Debates

Adherence – Don’t Remind Me!

The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course

Adherence – Don’t Remind Me!

https://pharmaphorum.com/sales-marketing/adherence-dont-remind-me/

Engaging with HCPS: what do HCPs want from medical meetings?

There has been a myriad of reasons over the past few years to safely assume the popularity and

Engaging with HCPS: what do HCPs want from medical meetings?

https://pharmaphorum.com/webinars/webinars-on-demand/engaging-with-hcps-what-do-hcps-want-from-medical-meetings/

04/12/2018

UK pharma and integrated health

The concept of integrated healthcare is not new to the UK, where it has been discussed since the

UK pharma and integrated health

https://pharmaphorum.com/debates-insight-sales-marketing/uk-pharma-integrated-health/

11/23/2017

The evolution of pharma social media intelligence

Is your company a fully mature user of intelligence from social media, or is it still not tapping

The evolution of pharma social media intelligence

https://pharmaphorum.com/debates-insight-sales-marketing/evolution-pharma-social-media-intelligence/

Digital Debate: What happens when multichannel communications meet behavioural science?

How can we create smarter, more effective communications for HCPs and patients? What can be done to challenge

Digital Debate: What happens when multichannel communications meet behavioural science?

https://pharmaphorum.com/sales-marketing/debates-sales-marketing/unlearn-relearn-reimagine-multichannel-strategy-behavioural-science-perfect-partners-smarter-communications/

Improving commercial decisions with customer relationship network insights

Networks of influence are shifting the decision-making process for life sciences companies. It is no longer enough

Improving commercial decisions with customer relationship network insights

https://pharmaphorum.com/debates-insight-sales-marketing/improving-commercial-decisions-customer-relationship-network-insights/

19/09/2017

Pharma’s digital landscape: the evolution of multichannel strategy

What are the best ways to choose the right channels and the right content? And how can you plan to optimize operations further by cutting down on costs and approval times? Ddiscover how to optimize and streamline all content-related processes within a single platform: starting with concept development and ending with the final launch.

Pharma’s digital landscape: the evolution of multichannel strategy

https://pharmaphorum.com/debates-insight-sales-marketing/pharmas-digital-landscape-evolution-multichannel-strategy/

How to maximise the value of digital in medtech: preparing for digital transformation

Overview With a wealth of market and regulatory changes impacting the medtech sector, it’s time for digital technology

How to maximise the value of digital in medtech: preparing for digital transformation

https://pharmaphorum.com/debates-insight-digital/maximise-value-digital-medtech/

Powering pharma’s commercial teams with market access insights

Market access is influencing drug development and commercial launch strategy more than ever before, with 85% of

Powering pharma’s commercial teams with market access insights

https://pharmaphorum.com/debates-insight-market-access/powering-pharmas-commercial-teams/

1 2 3 4 5

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

Debates